Rezdiffra.

Swiss trademark · 817807 · Combined mark · In force

Register entry

Registration number
817807
Application number
10275/2024
Status
In force
Type
Combined mark
As registered
Rezdiffra. ((fig.))
Filed
Jul 19, 2024
Registered
Jul 23, 2024
Published
Jul 23, 2024
Protected until
Jul 19, 2034
Priority
22.01.2024 US
Language of procedure
German
Vienna classes
24.17.01, 24.17.02
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Patienten mit nicht-alkoholischer Steatohepatitis (NASH) mit Leberfibrose.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2024

    Registered

    Published in Swissreg on 23.07.2024

Parties

Holder

Madrigal Pharmaceuticals, Inc.

200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428, US

Agent

Walder Wyss AG

Seefeldstrasse 123 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.